Abstract 1873: Atebimetinib’s deep cyclic inhibition of MEK constrains MAPK-axis adaptive and acquired alterations in patients with RAS-mutant tumors.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Immuneering (United States)
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148852281